Press Releases
BioDelivery Sciences Files Annual Report 10-K and Complies with Nasdaq Marketplace Rule 5250(b)(2)
Business Wire | 5 hours 16 minutes ago
BioDelivery Sciences International, Inc. (Nasdaq:BDSI) has filed its Annual Report with the U.S. Securities and Exchange Commission on Form 10-K for the fiscal year ended December 31, 2009. Such Form 10-K is available on the SEC’s website at www.sec.gov.... (more)
Brookdale to Present at Barclays Capital Global Healthcare Conference March 24
PRNewswire | 5 hours 46 minutes ago
NASHVILLE, Tenn., March 19 /PRNewswire-FirstCall/ -- Brookdale Senior Living Inc. (NYSE: BKD) today announced that Mark Ohlendorf, Co-President and Chief Financial Officer, will make a presentation regarding the Company at the Barclays Capital Global Healthcare Conference in Miami Beach, Florida on Wednesday, March 24, 2010, beginning at 8:00 a.m. Eastern Time.... (more)
Zacks Analyst Blog Highlights: Wal-Mart, Kimberly-Clark, Procter & Gamble, Bristol-Myers Squibb Company and AstraZeneca Plc
Business Wire | 5 hours 46 minutes ago
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Wal-Mart (NYSE: WMT), Kimberly-Clark (NYSE: KMB), Procter & Gamble (NYSE: PG), Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca Plc (NYSE: AZN).... (more)
Research and Markets: CareFusion Medical Device Company Intelligence Report
Business Wire | 11 hours 46 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/7247d2/carefusion_medical) has announced the addition of the "CareFusion Medical Device Company Intelligence Report" report to their offering.... (more)
Wall Street News Alert: Breaking News: UYMG - March 19, 2010
MarketWire | 13 hours 16 minutes ago
WESTON, FL -- (Marketwire) -- 03/19/10 -- Wall Street News Alert's "stocks to watch" this morning are: Unity Management Group Inc. (PINKSHEETS: UYMG), Boston Scientific Corporation (NYSE: BSX), UnitedHealth Group (NYSE: UNH) and Pfizer Inc. (NYSE: PFE). ... (more)
Blue Cross Blue Shield of Michigan Comments on Potential Sale of Detroit Medical Center to Vanguard Health
PRNewswire | 13 hours 46 minutes ago
DETROIT, March 19 /PRNewswire/ -- Blue Cross Blue Shield of Michigan president and CEO Daniel J. Loepp issued the following statement today in reaction to the announced sale of the nonprofit Detroit Medical Center to Nashville, Tenn.-based Vanguard Health Systems, a for-profit enterprise.... (more)
Bovie Medical Corporation Announces Clearance to Market Its BOSS Soft Tissue Coagulation Device
Business Wire | 13 hours 46 minutes ago
Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration (FDA) to market its proprietary BOSS™ bipolar sintered steel coagulation device. The BOSS™ is the latest device based on Bovie’s saline enhanced sintered steel technology.... (more)
Baxter International First Quarter 2010 Financial Results Conference Call
Business Wire | 13 hours 46 minutes ago
Baxter International (NYSE:BAX) will host a quarterly conference call to discuss its first quarter 2010 financial results on Thursday, April 22, 2010, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866-261-7280 (domestic) or 703-639-1228 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you.... (more)
OSI Pharmaceuticals Announces That Tarceva Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer
Business Wire | 15 hours 16 minutes ago
OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with stable disease following four cycles of standard platinum-based first-line chemotherapy. A final de...... (more)
Research and Markets: The Instant Impact on Insurance Lawyers of Bausch & Lomb, Inc. v. Lexington Ins. Co. (W.D.N.Y. Dec. 28, 2009)
Business Wire | 15 hours 46 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/7e6c92/the_instant_impact) has announced the addition of the "The Instant Impact on Insurance Lawyers of Bausch & Lomb, Inc. v. Lexington Ins. Co. (W.D.N.Y. Dec. 28, 2009) on Aggregating Claims Arising from the Same Product Defect and the Definition of Occurrence" audioconference to their offering.... (more)
Cytokinetics Announces Opening of a Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 for Patients With Amyotrophic Lateral Sclerosis
MarketWire | 15 hours 46 minutes ago
SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 03/19/10 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that the company has opened a Phase IIa "Evidence of Effect" (EoE) clinical trial of CK-2017357 for patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. CK-2017357 is a fast skeletal muscle troponin activator and is the lead drug candidate that has emerged from the company's skeletal muscle contractility program. CK-2017357 selectively activates ...... (more)
140 Press Releases | 
RSS Feed
Sign up for AANP SmartBrief
Latest Blog Postsview more
All High-Risk Pools Are Not Equal: Examining The Minnesota Model
Health Affairs Blog
Vote Yes
Health Care Blog, The
This will well-reward your time
Stayin' Alive
The Health Care Reform Reconciliation Bill
Health Affairs Blog
Companies in the news
- Alkermes Inc
- Boston Scientific Corporation
- Covidien plc
- Eli Lilly and Co.
- Eureko BV
- Genzyme Corp.
- GlaxoSmithKline Inc.
- Guidant Corp.